+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Biotech Ingredient Market Report 2025 - Product Thumbnail Image

Biotech Ingredient Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Neurofibromatosis Type 2 - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibromatosis Type 2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leptomeningeal Disease -Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Disease -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Smart Life Sciences Manufacturing Market Report 2025 - Product Thumbnail Image

Smart Life Sciences Manufacturing Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Patient Recruitment and Retention Services Market, 2019-2030 - Product Thumbnail Image

Patient Recruitment and Retention Services Market, 2019-2030

  • Report
  • February 2019
  • 300 Pages
  • Global
From
OX-40 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

OX-40 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator